Company intelligence
Hanson Wade
Better Drugs to Patients Faster
About Hanson Wade
Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations. Our events focus on researching, qualifying and curating valuable knowledge and insight in complex niches of drug discovery and development. We provide definitive quality that attendees trust to get better drugs to patients faster.
Verified activity
Signals from Hanson Wade
9 published signals
Presence & Recognition
Hanson Wade announced that the 16th World Clinical Biomarkers & Companion Diagnostics Summit is returning with its largest and most comprehensive edition, expanding the conference agenda to include multimodal datasets, foundational and AI/ML models operationalizing predictive biomarkers and endpoints in trials.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade notes that scientists from Bristol Myers Squibb, Pfizer, Novartis, Eli Lilly, Frontier Medicines, Dana-Farber Cancer Institute, Biogen, and Takeda will share how they tackle translating covalent assets into development-ready therapeutics at the 4th Covalent Drug Discovery & Development Summit.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade attended the Research Breakthroughs Day at the 9th TPD & Induced Proximity Summit in Boston, MA.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade and Hanson Wade's company are attending the 2nd Model-Informed Drug Development Summit in Boston from November 17-19, 2026, featuring leaders from FDA, Health Canada, Eli Lilly, Sanofi, GSK, AbbVie, Novartis, and Amgen.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade notes that radiopharmaceutical supply chain, manufacturing, CMC, quality, and logistics leaders will gather in Boston for the 4th TRP Supply Chain & Manufacturing Summit in Boston from September 15-17, 2026.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade highlighted a pre-conference workshop at the 2nd T-Cell Engager for Autoimmune Disease Summit focused on autoimmune T-cell engager development.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade highlighted the Protein Design & Engineering in Biopharma Summit 2026 agenda featuring sessions on protein therapeutics, multispecifics, T-Cell Engagers, and immune cell engagers in Boston.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade attended an interactive roundtable hosted by the Biospecimen Management Consortium (BMC) featuring Amy Ripston, Co-Founder and President.
Reported by Hanson Wade
Presence & Recognition
Hanson Wade announced the Advancing Data Center Construction East 2026 agenda featuring practical case studies and industry insights.
Reported by Kamilla Zaripova